Navigation Links
Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT
Date:5/12/2008

GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI) today said that it will host a conference call and live webcast tomorrow to discuss today's announcement that Intercell AG (VSE: ICLL) and Iomai have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million (EUR 122 million).

The conference call and webcast will be held at 8:30 a.m. Eastern Time tomorrow, Tuesday, May 13.

Conference Call Details

To access the live conference call Tuesday, May 13, 2008 at 8:30 a.m. Eastern Time via phone, please dial 866-713-8395 from the United States and Canada or 617-597-5309 internationally. The conference ID is 32511819. Please dial in approximately 10 minutes prior to the start of the call.

To access the live webcast, go to the Investor Relations section of the Company's website at http://www.iomai.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

ABOUT IOMAI CORPORATION

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a no
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
2. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
3. Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17
4. Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
5. Iomai Reports Going Concern Qualification in 10-K
6. Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine
7. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
10. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Mich., Aug. 29 /PRNewswire/ -- In response to rec... chronic wasting disease (CWD),members of the dee...ement., With hunting season fast approaching, the... a deer on a Kent County farm understandably has,c...and deer farmers across,the great state of Michiga...
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... Trusted life science software provid...ents to engage via GSA. , ...ns, an emerging software engineering firm dedicat...U.S. General Services Administration (GSA) Contrac...omers with the ability to conveniently engage 5AM ...
(Date:8/28/2008)... will lead clinical efforts of the Maryland Medica.../ -- KePRO, a national medical,management firm, ap...of,Medical Director. Dr. Lawyer will oversee all c...rmed in KePRO,s Hunt Valley, Maryland Harrisburg,o...cal career in Maryland," said,Alice Stollenwerk Pe...
Breaking Medicine News(10 mins):Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...er retinoblastoma has been developed by scientists...nstrated// in a mouse model to cause a remarkable ...g the side effects common with standard chemothera...suitable for certain forms of breast, lung, prosta...
...ive pulmonary disease (COPD) attempt to repair dam...s finding is in contradiction with the convention...he finding is important because it could pave the ...on' key genes to allow the lung to grow new alveol...
...haviors of human beings has found that concerns ov...are unfounded.// Monogamy is still held in esteem ...y are published in The Lancet. The research has g...ch found that people were in single relationships ...
... tackled by more action and less talk according to...ter// voiced support for higher taxes on drinks. ...cottish Health Action on Alcohol Problems (SHAAP) ...alth problems and push for action to cut alcohol m...
Other Medicine News:Health News:Revolutionary Eye Cancer Treatment 2Health News:Revolutionary Eye Cancer Treatment 3Health News:Revolutionary Eye Cancer Treatment 4Health News:Lungs repair themselves 2Health News:Alcohol Abuse Must be solved with Action 2
(Date:8/27/2008)...ust 27 /-, - Oralair(R) Gr...Pharmacodynamic Study Conducted in an Allergen Cha...ighly positive results of a new study,conducted in...on Oralair(R) Grasses included 86 adult patients e...eatment durations: 1 week, 1 month,2 and 4 months...
(Date:8/26/2008)...6 /- The Oregon Tourism Commission,la...ervice Training Program,(Q Care) this week on htt...ining program created to support the tourism and,h...ation. By emphasizing,the importance of quality cu...with tools and resources to better serve Oregon,s ...
(Date:8/26/2008)...26 /- Semafore Pharmaceuticals Inc.,p...s on Targeted Therapies,in Cancer in Washington, D...ted kinase inhibitors that demonstrate significant...ovel and proprietary molecular scaffold has been d... the design of pan-PI3 kinase inhibitors,as well a...
(Date:8/26/2008)... 26 /- Cambridge Research &,Instrumen...estro(TM) EX In,Vivo Imaging System. The new syste...ogy and becomes the entry-level instrument of choi...tp://www.newscom.com/cgi-bin/prnh/20080826/NETU054...ancement of CRi,s unique,solid-state tunable optic...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 1Hormonal Changes and Depression 3A What is the Connection 3F 6212 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 3Hormonal Changes and Depression 3A What is the Connection 3F 6212 4Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 1Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 2Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 363 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 163 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 2How much fish have we got 3F 1202 1How much fish have we got 3F 1202 2How much fish have we got 3F 1202 3
...primary and secondary endpoints of,study; no negat...opicitabine and ribavirin ~, CAMBRIDGE, Mass., Jun...ceuticals, Inc. today announced results from a pha...n therapy, consisting of,valopicitabine (NM283), I...epatitis C, pegylated interferon and ribavirin,com...
...07 /PRNewswire/ -- Accera, Inc.,today is presentin...Ib clinical trial of AC-1202 (Ketasyn) in Alzheime...International Conference on,Prevention of Dementia...of earlier clinical and preclinical studies, AC-12...ve the memory and,cognition of subjects of a parti...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value.
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Medicine Products: